Deeply Implantable, Shape-Morphing, 3D MicroLEDs for Pancreatic Cancer Therapy

Area of Science:

• Biomedical Engineering
• Oncology
• Photomedicine

Background:

• Collagens in the tumor microenvironment contribute to desmoplasia and immune suppression.
• Effective light delivery to solid tumors, especially dynamic ones like pancreatic ductal adenocarcinoma (PDAC), is crucial for photodynamic therapy but remains a challenge.
• Current methods struggle with sustained light activation due to tumor movement and volumetric changes.

Purpose of the Study:

• To introduce 3D, shape-morphing implantable photonic devices (IPDs) for tumor-specific and continuous light irradiation.
• To evaluate the efficacy of metronomic photodynamic therapy (mPDT) using IPDs in PDAC models.
• To address challenges in light delivery for sustained phototherapy in dynamic tumors.

Main Methods:

• Development of 3D, shape-morphing implantable photonic devices (IPDs) designed for seamless adhesion to tumor surfaces.
• Application of mPDT using IPDs in orthotopic PDAC mouse models.
• Assessment of tumor volume reduction, desmoplasia, and immune responsiveness post-treatment.

Main Results:

• The IPDs adhered effectively to orthotopic PDAC tumors, overcoming issues of mechanical mismatch and delamination.
• mPDT with IPDs significantly reduced desmoplastic tumor volume in freely moving mouse models.
• The treatment demonstrated efficacy without causing cytotoxic effects in surrounding healthy tissues.

Conclusions:

• Adaptable and unidirectional IPDs offer a promising approach for precise light delivery in cancer therapy.
• This technology facilitates effective metronomic photodynamic therapy for challenging tumors like PDAC.
• The findings represent a significant advancement in light-based therapeutic technologies for targeted cancer treatment.